In a new study, patients treated with one-fourth of the dose of beta-blockers tested in large clinical trials had a 20 to 25 percent increase in survival, indicating that dosing likely needs to be personalized for patients to get the best benefit.
Teresa Mastin, PhD, the new Director of Diversity and Inclusion, joins Feinberg to strengthen and expand diversity and inclusion efforts across the medical school.
Dan Foltz, ’02 PhD, Panagiotis Ntziachristos, PhD, and Marc Mendillo, PhD, have joined the Department of Biochemistry and Molecular Genetics.
At the Fourth Annual Driskill Day, students, faculty members and alumni gathered to present research, recognize achievement and celebrate the Walter S. and Lucienne Driskill Graduate Training Program in Life Sciences.
A new imaging technique that allows for visualization of blood flow in real-time revealed that abnormal blood flow from the two-flap valve in bicuspid aortic valve disease can create weakness in the aorta.
A study co-authored by Northwestern Medicine scientist Rintaro Hashizume, MD, PhD, identified the EAG2 potassium channel as a target for treating medulloblastoma.
Alisha Thomas, ’05 MD, instructor of Clinical Family and Community Medicine, has been recognized with the Exemplary Teaching Award for volunteer faculty by the American Association of Family Physicians.
In a recent study, Northwestern Medicine scientists described a new process that explains how the adhesion between epithelial cells occurs.
Fatima Eldigair, a Sudanese-American senior at Lincoln Park High School, brought Feinberg’s Oncofertility Summer Academy to Sudan at the beginning of August to teach students there about cancer, reproductive biology and bioengineering.
A multi-center team of scientists have received funding from the National Cancer Institute to develop compounds that may lead to an entirely new treatment for Acute Myeloid Leukemia (AML). The grant, which will provide $1.58 million over three years, will support medicinal chemistry, molecular modeling, and biological testing to optimize small molecule CXCR4-receptor antagonists and…